Umbilical Cord Serum Eyedrops
Showing 1 - 25 of >10,000
Dry Eye Syndromes Trial in Cheras, Kuala Lumpur (Optive, Ophthalmic Solution, Umbilical Cord Serum eye drops, Genteal lubricant
Recruiting
- Dry Eye Syndromes
- Optive, Ophthalmic Solution
- +2 more
-
Cheras, Kuala Lumpur, Malaysia
- +2 more
Sep 18, 2020
Heart Failure, Systolic Trial in Shanghai (human umbilical cord mesenchymal stem cells, human serum albumin)
Recruiting
- Heart Failure, Systolic
- human umbilical cord mesenchymal stem cells
- human serum albumin
-
Shanghai, Shanghai, ChinaHeart Failure Department, East Hospital Affiliated to Tongji Uni
Nov 10, 2021
Decompensated Cirrhosis Trial in China (UC-MSCs, Saline containing 1% Human serum albumin(solution without UC-MSCs))
Recruiting
- Decompensated Cirrhosis
- UC-MSCs
- Saline containing 1% Human serum albumin(solution without UC-MSCs)
-
Lanzhou, Gansu, China
- +4 more
Nov 3, 2021
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived
Completed
- Keloid
- Stem Cell
- umbilical cord-derived mesenchymal stem cells (UC-MSC)
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSPAD Gatot Soebroto
Jul 1, 2023
Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))
Recruiting
- Severe Aplastic Anemia
- Anti-Thymocyte Globulin (Rabbit)
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Sep 9, 2023
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Jul 28, 2022
Decompensated Liver Cirrhosis Trial (Human Umbilical Cord Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Liver Cirrhosis
- Human Umbilical Cord Mesenchymal Stem Cells
- (no location specified)
Jul 13, 2023
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Human umbilical cord mesenchymal stem cells
- Interleukin-2
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022
Ischemic Heart Disease Trial in Miami, Louisville, Houston (umbilical cord-derived mesenchymal stromal cells (UC-MSCs))
Not yet recruiting
- Ischemic Heart Disease
- umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
-
Miami, Florida
- +2 more
Nov 17, 2023
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)
Recruiting
- COVID-19
- Umbilical cord mesenchymal stem cells implantation
- Comparator
-
Shijiazhuang, Hebei, ChinaThe First Hospital of Hebei Medical University
Feb 22, 2023
HBV Trial in Wuhan (hUCMSCs)
Recruiting
- HBV
- hUCMSCs
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 27, 2022
Ischemic Bowel Disease Trial in JiNan (Human Umbilical Cord blood mononuclear cells)
Recruiting
- Ischemic Bowel Disease
- Human Umbilical Cord blood mononuclear cells
-
JiNan, Shandong, ChinaHongLi Yang
Sep 26, 2022
Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- CK0803
- Excipient
-
New York, New YorkColumbia University Irving Medical Center
Jan 26, 2023
Ischemic Stroke Trial in Shenyang (Umbilical Cord-derived Mesenchymal Stem Cells, Placebo)
Recruiting
- Ischemic Stroke
- Umbilical Cord-derived Mesenchymal Stem Cells
- Placebo
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
May 24, 2022
Polycystic Ovary Syndrome Trial in Jakarta (WJ-MSCs, Secretomes, WJ-MSCs and Secretomes)
Recruiting
- Polycystic Ovary Syndrome
- UC-MSCs
- +3 more
-
Jakarta, IndonesiaPT Prodia StemCell Indonesia
Sep 23, 2022
l Research to Identify Disease Mechanism(s)
Recruiting
- Undiagnosed Diseases
- Cardiovascular Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 30, 2022
Vitamin D Deficiency Trial in Makasar (Anthropometric measurement for pregnant women, Anthropometric measurement for infants,
Recruiting
- Vitamin D Deficiency
- Anthropometric measurement for pregnant women
- +2 more
-
Makasar, South Sulawesi, IndonesiaHasanuddin University
Jun 25, 2022
Umbilical Cord Clamping Trial in Cairo (Documentation of Maternal blood loss and neonatal outcome)
Completed
- Umbilical Cord Clamping
- Documentation of Maternal blood loss and neonatal outcome
-
Cairo, EgyptFaculty of Medicine - Cairo University
Feb 7, 2022
Congenital Diaphragmatic Hernia Trial in Houston (Autologous umbilical cord blood)
Recruiting
- Congenital Diaphragmatic Hernia
- Autologous umbilical cord blood
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 31, 2022
Cirrhosis Due to Hepatitis B Trial in Wuhan (UC-MSCs, Saline solution)
Recruiting
- Cirrhosis Due to Hepatitis B
- UC-MSCs
- Saline solution
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Aug 18, 2022
COVID-19, Acute Respiratory Distress Syndrome, Corona Virus Infection Trial (UCMSCs, Placebo)
Withdrawn
- COVID-19
- +2 more
- UCMSCs
- Placebo
- (no location specified)
May 6, 2022